Four Breast Cancer/Environment Research Centers Created

Publication
Article
OncologyONCOLOGY Vol 18 No 1
Volume 18
Issue 1

Four newly created Breast Cancer and the Environment ResearchCenters will work together in a $35 million effort to investigatethe prenatal to adult environmental factors that may predisposewoman to developing breast cancer. The centers, jointly financed bythe National Cancer Institute and the National Institute of EnvironmentalHealth Sciences, will receive $5 million annually for 7 years.

Four newly created Breast Cancer and the Environment Research Centers will work together in a $35 million effort to investigate the prenatal to adult environmental factors that may predispose woman to developing breast cancer. The centers, jointly financed by the National Cancer Institute and the National Institute of Environmental Health Sciences, will receive $5 million annually for 7 years. The new research centers will be located at the University of Cincinnati, Fox Chase Cancer Center, University of California, San Francisco, and Michigan State University, East Lansing. The quartet will act as a single program, although with some specialization at each center, and will collaborate on several research fronts.

Recent Videos
Updated results from the 1b/2 ELEVATE study elucidate synergizing effects observed with elacestrant plus targeted therapies in ER+/HER2– breast cancer.
Patients with ESR1+, ER+/HER2– breast cancer resistant to chemotherapy may benefit from combination therapy with elacestrant.
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Related Content